China · Delayed Price · Currency is CNY Shanghai Shenqi Pharmaceutical Investment Management Company Description
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China.
The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields.
Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.
| Country | China |
| Founded | 1990 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 1,266 |
| CEO | Feng Bin |
Contact Details
Address: Changfa Building Shanghai, 200003 China | |
| Phone | 86 21 5375 0009 |
| Website | gzsq.com |
Stock Details
| Ticker Symbol | 600613 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000453 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Feng Bin | GM and Director |
| Zhimian Chen | Chief Financial Officer and Director |
| Kejing Wu | Board Secretary |
| Xiajuan Wang | Accounting Supervisor |